The largest database of trusted experimental protocols

5 aza 2 deoxycytidine aza

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom

5-aza-2'-deoxycytidine (AZA) is a chemical compound used in laboratory research. It is a synthetic analog of the DNA nucleoside cytidine. AZA is commonly used as a DNA methylation inhibitor in cell culture experiments.

Automatically generated - may contain errors

47 protocols using 5 aza 2 deoxycytidine aza

1

Epigenetic Modulation of hiPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AlphoidtetO-HAC-GFP hiPSCs were cultured for 24 h in mTeSR-1 media in the presence of DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (AZA) (Sigma-Aldrich, St. Louis, MO, USA) or histone deacetylase inhibitor trichostatin A (TSA) (Sigma-Aldrich, St. Louis, MO, USA) at concentrations of 5–10 μM and 0.5 μM, respectively. The AlphoidtetO-HAC-GFP hiPSCs were cultured for 72 h in the presence of 100–400 nM AZA or 19–38 nM TSA. The GFP-expression in the living cells was monitored by fluorescent and phase contrast light microscopy (EVOS FL Auto Imaging System, Thermo Fisher Scientific, Waltham, MA, USA).
The AlphoidtetO-HAC-GFP hiPSCs were cultured for 24 h in mTeSR-1 media in the presence of DNA methyltransferase inhibitor 5-Aza-2’-deoxycytidine (AZA) (Sigma-Aldrich, St. Louis, MO, USA) or histone deacetylase inhibitor trichostatin A (TSA) (Sigma-Aldrich, St. Louis, MO, USA) at concentrations of 5–10 μM and 0.5 μM, respectively. The AlphoidtetO-HAC-GFP hiPSCs were cultured for 72 h in the presence of 100–400 nM AZA or 19–38 nM TSA. The GFP-expression in the living cells was monitored by fluorescent and phase contrast light microscopy (EVOS FL Auto Imaging System, Thermo Fisher Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
2

Transcriptional Profiling of Melanoma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA samples of paired melanoma cell lines IGR39 and IGR37 were extracted and sent to the IRB Functional Genomic Core External Service (Barcelona). Once samples had been reversed-transcribed and labeled, they were hybridized onto Affymetrix GeneChip Human Genome U133 Plus 2.0 arrays. Hybridization, washing, staining and scanning were performed using Affymetrix GeneChip system instruments and protocols. For breast and colon cancer cell lines, expression data were obtained from the Gene Expression Omnibus (GSE11683, GSE10843 and GSE57083). For qRT–PCR experiments, total RNA was extracted using Trizol reagent and retrotranscribed using the ThermoScript RT-PCR system (Invitrogen). The reaction was carried out following the methods for use of SYBR Green (Applied Biosystems), and B2M, GAPDH and ACTB were used as housekeeping genes to enable normalization. For primer sequences please refer to Supplementary Table 3. We performed reactivation treatments with the demethylating agent 5-aza-2′-deoxycytidine (AZA; Sigma) at 0.5 μM for 72 h. For immunoblotting assays, we extracted total protein using RIPA (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA and EGTA, 1% NP40, 0.5% of sodium deoxycholate, 0.1% of SDS, and protease and phosphatase inhibitors from Roche). All the antibodies used in this study are described in Supplementary Table 3.
+ Open protocol
+ Expand
3

Synergistic Gene Reactivation by DNMT and HDAC Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
5-aza-2′-deoxycytidine (5-aza-dC), a DNA methyltransferase (DNMT) inhibitor, makes DNMT inactivation through DNMT covalent bonding with thiol on cysteine residues, resulting in reactivation genes silenced by promoter methylation. Trichostatin A (TSA), a histone deacetylase inhibitor, plays a significant role in controlling the tightness of DNA around histone. Combination treatment of TSA and 5-Aza-dC results in the synergistic activation of methylated genes.
As previously described [32 (link)], breast cancer cell lines were treated with 10 mmol/L 5-aza-2-deoxycytidine (Aza) (Sigma-Aldrich, Steinheim, Germany) for 3 days and further treated with or without 100 nmol/L TSA (Sigma-Aldrich) for an additional 24 h.
+ Open protocol
+ Expand
4

Epigenetic Regulation of Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagents used were as follows: Palbociclib (0.1 μM or 0.3 μM, Selleck Chemicals, Cat #S1116), 4-Hydroxytamoxifen (0.5 μM, Sigma, Cat #h7904), Trichostatin A (0.3 μM, Sigma, Cat #T8552), Entinostat (1 μM, Cayman Chemical, Cat #13284), DZNep (1 μM, Cayman Chemical, Cat #13828), 2-PCPA (200 μM, Cayman Chemical, Cat #10010494), GSK-LSD1 (1 μM, Santa Cruz, Cat #sc-490345), and 5-Aza-2′-deoxycytidine (AZA) (10 μM, Sigma, Cat #A3656). VT02956 and VT02484 were provided by Vivace Therapeutics.
+ Open protocol
+ Expand
5

Generation of Induced Decidual Natural Killer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conversion of pNK cells to idNK cells were done as previously described [36 ]. Briefly, NK RosetteSep enriched pNK cells were seeded at 1 X 106 cells/ml in IL-15 complete media with the addition of recombinant human TGF-β1 (PeproTech) at 2 ng/ml, 1 μM 5-aza-2-deoxycytidine (Aza) (Sigma-Aldrich, St Louis, MO), and maintained in culture 7 days (for injection at gd9) or 10 days (for injection at gd12) at 37°C in humidified incubators in a 1% O2 and 5% CO2 atmosphere. To assess conversion efficiency, the percentage of CD9+ KIR+ cells among the CD16- CD56Bright and CD16+ CD56Dim idNK populations was evaluated by flow cytometry after 6 or 7 days in culture. For microarray gene expression profiling, CD3- CD16- CD56Bright CD9+ KIR+ idNK and CD3- CD16+ CD56Dim CD9+ KIR+ idNK cells were further purified from the idNK cell bulk preparation by FACS.
+ Open protocol
+ Expand
6

Regulation of Retinal Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human retinal endothelial cells (Cell system, Kirkland, WA) from 7–8th passage were incubated in NG or HG media containing 1% fetal calf serum, 9% Nu-serum and 1 µg/mL endothelial growth supplement for 4 days13 (link),14 (link). Cell incubated in high glucose were divided into two groups, cells in group 1 remained in high glucose for eight days, in the absence or presence of 1 µM 5-aza-2′-deoxycytidine (Aza; Sigma-Aldrich Corp, St. Louis, MO, USA), respectively. In group 2, after four days of high glucose exposure, the cells were incubated in normal glucose for four additional days, in the absence or presence of Aza (HG-NG and HG-NG/Aza). For osmotic/ metabolic control, 20 mM D-glucose was replaced by 20mM L-glucose (L-Gl). As reported previously, under these incubation conditions, morphology of HRECs was maintained22 (link).
+ Open protocol
+ Expand
7

Reactivating FOXO1 Transcription in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell lines HeLa, SiHa, ME180 and SW756 were treated with 5-Aza-2'-deoxycytidine (AZA) (Sigma, USA) and HDAC inhibitor Trichostatin A (TSA) (Sigma, USA) as described previously in 25 (link) to reactivate FOXO1 transcription. For cell proliferation, cell viability and apoptosis, cells were initially grown in 96-well plate (1x104 cells/well) and 6-well plate (1x105 cells/well) for 24hr, followed by treatment with 10µM and 25 µM of LY294002 for 48hr.
+ Open protocol
+ Expand
8

Breast Cancer Cell Line DNA Demethylation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Breast cancer cell lines were subjected to DNA demethylation treatments, as previously described [8 (link)]. Cell lines were treated with 10 mM 5-aza-2′-deoxycytidine (Aza) (Sigma-Aldrich, Steinheim, Germany) for 3 days, and then treated with 100 nM trichostatin A (TSA) (Sigma-Aldrich, Steinheim, Germany) for an additional 24 h.
+ Open protocol
+ Expand
9

qRT-PCR and Immunoblotting Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For qRT–PCR experiments, total RNA was extracted using Trizol® reagent and retrotranscribed using the ThermoScript™ RT–PCR System (Invitrogen). The reaction was carried out following the methods for use of SYBR Green (Applied Biosystems), and HPRT were used as housekeeping gene to enable normalization. Reactivation treatments with the demethylating agent 5-aza-2′-deoxycytidine (AZA; Sigma) were performed at 1 μM for 72 h. For immunoblotting assays, total protein was extracted using RIPA (50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA and EGTA, 1% NP40, 0.5% of sodium deoxycholate, 0.1% of SDS, and protease and phosphatase inhibitors from Roche), and specific antibodies against target proteins are listed in the enclosed table.
+ Open protocol
+ Expand
10

Quantitative RNA Analysis with AZA Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
For real-time quantitative reverse transcription-PCR experiments, total RNA was extracted using the SimplyRNA kit (Promega) on a Maxwell RSC device (Promega) and retrotranscribed using the ThermoScript RT-PCR system (ThermoFisher) with oligo(dT) primers. The reaction was carried out following the methods for the use of SYBR Green (Applied Biosystems), and GAPDH was used as housekeeping genes to enable normalization. Primers for qPCR are listed in the supplementary Key Resources Table. Reactivation treatments with the demethylating agent 5-aza-2′-deoxycytidine (AZA; Sigma) were performed at 0.5 µM for 72 h. For immunoblotting assays, we extracted cell pellets and brain white matter samples with 300 µL of RIPA buffer containing protease and phosphatase inhibitors cocktail cOmplete™ (Roche). Antibodies used in this study are described in supplementary Key Resources Table.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!